Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy.
about
Core signaling pathways in human pancreatic cancers revealed by global genomic analysesDiscovery of cellular regulation by protein degradationIntegrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersEstablishment and genetic characterization of six unique tumor cell lines as preclinical models for sinonasal squamous cell carcinoma6-thioguanine: a drug with unrealized potential for cancer therapy.A general approach for receptor and antibody-targeted detection of native proteins utilizing split-luciferase reassembly.Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.Targeting cancer's weaknesses (not its strengths): Therapeutic strategies suggested by the atavistic modelBringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin MelanomaCell cycle dependence of ionizing radiation-induced DNA deletions and antioxidant radioprotection in Saccharomyces cerevisiaeTurn-on DNA damage sensors for the direct detection of 8-oxoguanine and photoproducts in native DNA.The simple and rapid detection of specific PCR products from bacterial genomes using Zn finger proteins.Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.A systems approach defining constraints of the genome architecture on lineage selection and evolvability during somatic cancer evolutionToward a general approach for RNA-templated hierarchical assembly of split-proteins.Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma.Natural selection: The evolution of cancer.
P2860
Q24606006-7BD3B7F9-8642-430F-910E-F275349AE385Q24607508-E7DA3BB7-B700-4FDE-BE4E-3A12E8CBA2FFQ24649562-18AD7975-D4D6-4F8B-96EA-FA88DC059B7CQ33595483-46695183-E0EB-45FF-89C7-9E40F3A2C618Q33829767-6768C5A2-065F-4177-A4BE-3785B90FC096Q34204188-F0D069D9-AFD7-42C4-AF46-CAD956DD6B39Q34280594-EDE5C158-CF5F-4448-8044-6B1229AA2591Q34807615-1A9B1DEF-1097-47D2-BA96-3AA7E14C4658Q35840622-EE86AD39-5618-40F1-AA7E-C56A70D919C1Q37414974-08E3AED3-5EF9-4CD8-A47F-9010C6C01AB1Q38335681-BB320B92-AEE6-4C0A-B01F-2C488BCD25CCQ39634395-5C79534C-58B3-4E05-A317-E4E18E270758Q39752244-709BEFFD-3C0C-469C-9919-7DEAC1944B83Q41882366-6A22A179-CAFA-4B5A-B51D-5BAD17CEFA85Q42410081-1CC1099F-E13C-4264-929B-D9C53D72C88CQ52832002-A074B03E-1CCA-4A67-8520-DF9929A5CF0BQ53318099-2F0FD91A-0723-49C8-BB38-6F1D039D8A57
P2860
Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeting the absence: homozyg ...... signposts for cancer therapy.
@ast
Targeting the absence: homozyg ...... signposts for cancer therapy.
@en
type
label
Targeting the absence: homozyg ...... signposts for cancer therapy.
@ast
Targeting the absence: homozyg ...... signposts for cancer therapy.
@en
prefLabel
Targeting the absence: homozyg ...... signposts for cancer therapy.
@ast
Targeting the absence: homozyg ...... signposts for cancer therapy.
@en
P2860
P356
P1476
Targeting the absence: homozyg ...... signposts for cancer therapy.
@en
P2093
Alexander Varshavsky
P2860
P304
14935-14940
P356
10.1073/PNAS.0706546104
P407
P577
2007-09-10T00:00:00Z